Zimbabwe has declined a major American health deal valued at 367 million US dollars (£272m) spanning five years because of Washington's demand for sensitive data.
This move became public following a official document dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesperson has since explained that the US was requesting genetic material for research and profit but was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had furnished over $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for continued dialogue to secure a agreement acceptable to all parties so the nation's vital HIV programme can proceed.
Broader Background
This rejection comes after a comparable case in neighbouring Kenya, where a high court suspended a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to enhance openness and responsibility.
According to statements, Sixteen African countries have to date agreed to these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation would have delivered significant benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to provide its biological resources and data for a long time, with no equivalent guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our nation would provide the raw materials for medical research with no certainty that the end products would be accessible to our citizens if a future disease outbreak arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting structures already established through the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This system is intended to guarantee that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage further discussions with our US partners on how subsequent co-operation could be designed in a manner that honours the sovereignty and dignity of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but urged that talks need to persist considering much of the country's HIV programmes relied on external financing.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it commented.
This impasse highlights the ongoing tensions between accepting much-needed foreign assistance and safeguarding national sovereignty in an ever more interconnected world.